Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Researchers in Canada report progress in crafting a vaccine containing 10 different proteins that could prevent hepatitis C infectionless likely to adhere to their anti-HIV drug regimens than those only infected with HIV, according to a study in the February 14 edition of the journal AIDS. Canadian researchers, studying 1,186 HIVers found that HCV coinfection was a risk factor for adherence failure, defined as taking less than 95% of anti-HIV medications as prescribed. Male HIVers also were less likely to be adherent. An increase in ribavirin dosage may help improve responses to hepatitis C treatment in HIV-HCV coinfected adults, according to studies presented at the Second International Workshop on HIV and Hepatitis C Coinfection. Adjusting the dosage of ribavirin'marketed as Copegus, Rebetol, and Virazole'based on a patient's weight is more effective in controlling HCV than standard 800-milligram-per-day dosing, according to French researchers. Fatigue is commonly misdiagnosed as depression among HIV-HCV coinfected patients receiving anti-hepatitis drugs, according to a study by New York researchers. Depression is a common psychological side effect of hepatitis C therapy and a major reason treatment is halted. But the scientists reported at the Second International Workshop on HIV and Hepatitis C Coinfection that fatigue, usually caused by anemia, is more than twice as prevalent during HCV treatment than depression, but is commonly misdiagnosed. Measuring levels of ALT, an enzyme that is a marker of liver function, may be an inaccurate gauge of liver disease in HIV-HCV coinfected adults, according to a study in the January 1 edition of the Journal of Acquired Immune Deficiency Syndromes. Researchers found that 25% of patients with normal ALT levels actually had such severe liver damage that they required hepatitis treatment, with 13% having developed cirrhosis-related liver scarring. A study of 50 Spanish HIV patients who've undergone liver transplants due to hepatitis coinfection shows that the procedure is safe and effective in the short- and mid-term. The study showed that survival rates were 85% after one year, 75% after two years, and 66% after three years, levels similar to those seen in HIV-negative hepatitis patients who received liver transplants. Long-term success of hepatitis C therapy among HIV-HCV coinfected adults can be predicted by the early response to anti-hepatitis drugs after just four weeks of treatment, according to a study presented at the 13th Conference on Retroviruses and Opportunistic Infections. Among study patients who achieved a rapid virologic response to the medications, 95% maintained viral suppression through 24 weeks of treatment and 90% maintained suppression for at least another 24 weeks after drug therapy was stopped. Among those with a slower response to the drugs, only 69% achieved viral control by the end of the 24-week treatment period and only 37% maintained virologic suppression through the 24-week post-treatment follow-up.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Before AIDS, gay artist Rex drew hot men on the prowl — then he disappeared
April 11 2024 3:15 PM
Diets that mimic fasting reverse aging: study
March 07 2024 5:28 PM
The Most Amazing HIV Allies & Advocates of 2023
November 03 2023 12:51 PM
PrEP without a prescription now a reality in California
February 06 2024 8:37 PM
This OnlyFans Star Is Trying to Raise $100K to Fight HIV
December 26 2023 3:05 PM
Injectable HIV treatment, prevention: Everything you need to know
March 26 2024 3:28 PM
The naked Black body takes center stage in this HIV campaign
January 03 2024 1:07 PM
8 dating tips for gay men from a gay therapist
March 21 2024 2:50 PM
Mr. Gay World wants to make sure you're OK
January 02 2024 4:56 PM
Plus: Featured Video
Latest Stories
The government failed on mpox. Ritchie Torres's new bill addresses that
April 18 2024 1:21 PM
On Anal Sex Day, crack up with The Bottom's Digest
April 18 2024 10:22 AM
Todrick Hall has long supported the communities he comes from
April 17 2024 12:02 PM
Our May/June issue of Plus is here!
April 17 2024 12:00 PM
Giselle Byrd is taking center stage — and helping others do the same
April 10 2024 2:24 PM
Discover endless fun at The Pride Store: Games & electronics for all ages
April 09 2024 4:25 PM
Mean Girls' Daniel Franzese on playing an HIV+ character
April 09 2024 3:57 PM
HIV-positive Air Force, Navy servicemembers victorious in lawsuit
April 09 2024 3:02 PM
Unlocking a new level of beauty with Dr Botanicals' ethical skincare line
April 08 2024 3:40 PM
Unleash your wild side with The Pride Store’s beginner’s guide to kink
April 08 2024 3:35 PM
Why are mpox cases in the U.S. on the rise again?
April 08 2024 1:30 PM
Happy national foreskin day!
April 04 2024 1:45 PM
Adult entertainment icons Derek Kage & Cody Silver lead fight for free speech
April 03 2024 3:06 PM
LGBTQ+ patients twice as likely to face discrimination: survey
April 02 2024 4:57 PM
Spring into The Pride Store’s top new arrivals for April
April 02 2024 4:39 PM
Nashville PD Must Pay HIV-Positive Man Denied a Job
April 01 2024 6:22 PM
Common has a message on how to foster self-love
March 29 2024 7:33 PM
Listen to Dr. Levine: Take syphilis seriously
March 28 2024 6:40 PM
Breaking boundaries in gender-free fashion with Stuzo Clothing
March 27 2024 2:15 PM